Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Membranous Nephropathy Posttransplantation: An Update of the Pathophysiology and Management.

Leon J, Pérez-Sáez MJ, Batal I, Beck LH Jr, Rennke HG, Canaud G, Legendre C, Pascual J, Riella LV.

Transplantation. 2019 Oct;103(10):1990-2002. doi: 10.1097/TP.0000000000002758.

PMID:
31568231
2.

Temporal virus serological profiling of kidney graft recipients using VirScan.

Isnard P, Kula T, Avettand Fenoel V, Anglicheau D, Terzi F, Legendre C, Elledge SJ, Canaud G.

Proc Natl Acad Sci U S A. 2019 May 28;116(22):10899-10904. doi: 10.1073/pnas.1821166116. Epub 2019 May 13.

PMID:
31085644
3.

Membranous Nephropathy Post-Transplantation: An Update of the Pathophysiology and Management.

Leon J, Pérez-Sáez MJ, Batal I, Beck LH Jr, Rennke HG, Canaud G, Legendre C, Pascual J, Riella LV.

Transplantation. 2019 Apr 10. doi: 10.1097/TP.0000000000002758. [Epub ahead of print]

PMID:
30985736
4.

Author Correction: Targeted therapy in patients with PIK3CA-related overgrowth syndrome.

Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP, Blanc E, Johnson SC, Hoguin C, Boccara O, Sarnacki S, Boddaert N, Pannier S, Martinez F, Magassa S, Yamaguchi J, Knebelmann B, Merville P, Grenier N, Joly D, Cormier-Daire V, Michot C, Bole-Feysot C, Picard A, Soupre V, Lyonnet S, Sadoine J, Slimani L, Chaussain C, Laroche-Raynaud C, Guibaud L, Broissand C, Amiel J, Legendre C, Terzi F, Canaud G.

Nature. 2019 Apr;568(7752):E6. doi: 10.1038/s41586-019-1109-3.

PMID:
30944482
5.

Cyclin G1 and TASCC regulate kidney epithelial cell G2-M arrest and fibrotic maladaptive repair.

Canaud G, Brooks CR, Kishi S, Taguchi K, Nishimura K, Magassa S, Scott A, Hsiao LL, Ichimura T, Terzi F, Yang L, Bonventre JV.

Sci Transl Med. 2019 Jan 23;11(476). pii: eaav4754. doi: 10.1126/scitranslmed.aav4754.

PMID:
30674655
6.

mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.

Johnson SC, Martinez F, Bitto A, Gonzalez B, Tazaerslan C, Cohen C, Delaval L, Timsit J, Knebelmann B, Terzi F, Mahal T, Zhu Y, Morgan PG, Sedensky MM, Kaeberlein M, Legendre C, Suh Y, Canaud G.

Kidney Int. 2019 Feb;95(2):455-466. doi: 10.1016/j.kint.2018.08.038. Epub 2018 Nov 22.

PMID:
30471880
7.

Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases.

Arrestier R, Satie AP, Zhang SY, Plaisier E, Isnard-Bagnis C, Gatault P, Raimbourg Q, Buob D, Vocila F, Heng AE, Francois H, Moktefi A, Canaud G, Matignon M, Dejucq-Rainsford N, Brocheriou I, Sahali D, Audard V.

BMC Nephrol. 2018 Nov 20;19(1):331. doi: 10.1186/s12882-018-1132-x.

8.

Targeted therapy in patients with PIK3CA-related overgrowth syndrome.

Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP, Blanc E, Johnson SC, Hoguin C, Boccara O, Sarnacki S, Boddaert N, Pannier S, Martinez F, Magassa S, Yamaguchi J, Knebelmann B, Merville P, Grenier N, Joly D, Cormier-Daire V, Michot C, Bole-Feysot C, Picard A, Soupre V, Lyonnet S, Sadoine J, Slimani L, Chaussain C, Laroche-Raynaud C, Guibaud L, Broissand C, Amiel J, Legendre C, Terzi F, Canaud G.

Nature. 2018 Jun;558(7711):540-546. doi: 10.1038/s41586-018-0217-9. Epub 2018 Jun 13. Erratum in: Nature. 2019 Apr;568(7752):E6.

PMID:
29899452
9.

FSGS ACTH Gel: Part of the Answer?

Delville M, Canaud G, Legendre C.

Transplantation. 2019 Jan;103(1):15-16. doi: 10.1097/TP.0000000000002321. No abstract available.

PMID:
29894412
10.

Vascular endothelial growth factor backfiltration in the glomerulus: an intriguing mechanism.

Yamaguchi J, Canaud G.

Nephrol Dial Transplant. 2018 Sep 1;33(9):1483-1484. doi: 10.1093/ndt/gfy114. No abstract available.

PMID:
29718406
11.

mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G.

Hadjadj J, Canaud G, Mirault T, Samson M, Bruneval P, Régent A, Goulvestre C, Witko-Sarsat V, Costedoat-Chalumeau N, Guillevin L, Mouthon L, Terrier B; French Vasculitis Study Group.

Rheumatology (Oxford). 2018 Jun 1;57(6):1011-1020. doi: 10.1093/rheumatology/key017.

PMID:
29506143
12.

Anticardiolipin antibodies and 12-month graft function in kidney transplant recipients: a prognosis cohort survey.

Gauthier M, Canoui-Poitrine F, Guéry E, Desvaux D, Hue S, Canaud G, Stehle T, Lang P, Kofman T, Grimbert P, Matignon M.

Nephrol Dial Transplant. 2018 Apr 1;33(4):709-716. doi: 10.1093/ndt/gfx353.

PMID:
29346631
13.

Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?

Siddique S, Risse J, Canaud G, Zuily S.

Curr Rheumatol Rep. 2017 Sep 4;19(10):64. doi: 10.1007/s11926-017-0687-z. Review.

PMID:
28871481
14.

[PIK3CA-related overgrowth syndrome (PROS)].

Venot Q, Canaud G.

Nephrol Ther. 2017 Apr;13 Suppl 1:S155-S156. doi: 10.1016/j.nephro.2017.02.004. Review. French.

PMID:
28577738
15.

HIV Infection in the Native and Allograft Kidney: Implications for Management, Diagnosis, and Transplantation.

Avettand-Fenoël V, Rouzioux C, Legendre C, Canaud G.

Transplantation. 2017 Sep;101(9):2003-2008. doi: 10.1097/TP.0000000000001674. Review.

PMID:
28196049
16.

Antiphospholipid syndrome and kidney disease.

Bienaimé F, Legendre C, Terzi F, Canaud G.

Kidney Int. 2017 Jan;91(1):34-44. doi: 10.1016/j.kint.2016.06.026. Epub 2016 Aug 21. Review.

PMID:
27555120
17.

The costimulatory receptor B7-1 is not induced in injured podocytes.

Baye E, Gallazzini M, Delville M, Legendre C, Terzi F, Canaud G.

Kidney Int. 2016 Nov;90(5):1037-1044. doi: 10.1016/j.kint.2016.06.022. Epub 2016 Aug 12.

18.

Rituximab for Recurrence of Primary Focal Segmental Glomerulosclerosis After Kidney Transplantation: Clinical Outcomes.

Garrouste C, Canaud G, Büchler M, Rivalan J, Colosio C, Martinez F, Aniort J, Dudreuilh C, Pereira B, Caillard S, Philipponnet C, Anglicheau D, Heng AE.

Transplantation. 2017 Mar;101(3):649-656. doi: 10.1097/TP.0000000000001160.

PMID:
27043407
19.

Molecular pathways of chronic kidney disease progression.

Bienaimé F, Canaud G, El Karoui K, Gallazzini M, Terzi F.

Nephrol Ther. 2016 Apr;12 Suppl 1:S35-8. doi: 10.1016/j.nephro.2016.02.009. Epub 2016 Mar 10. Review.

PMID:
26972095
20.

B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.

Delville M, Baye E, Durrbach A, Audard V, Kofman T, Braun L, Olagne J, Nguyen C, Deschênes G, Moulin B, Delahousse M, Kesler-Roussey G, Beaudreuil S, Martinez F, Rabant M, Grimbert P, Gallazzini M, Terzi F, Legendre C, Canaud G.

J Am Soc Nephrol. 2016 Aug;27(8):2520-7. doi: 10.1681/ASN.2015091002. Epub 2015 Dec 23.

Supplemental Content

Loading ...
Support Center